In a remarkable display of market confidence, Oppenheimer Holdings Inc (NYSE:OPY). stock has reached an all-time high, ...

In a report released yesterday, Kristen Owen from Oppenheimer maintained a Buy rating on Cf Industries Holdings (CF – Research Report), with a ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

PETACH TIKVA, Israel, Jan. 30, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: PYPD), (“PolyPid” or the “Company”), a late-stage biopharma ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

AGCO (NYSE:AGCO – Get Free Report) had its price target raised by Oppenheimer from $108.00 to $109.00 in a research report ...

We recently compiled a list of the Goldman Sachs’ 35 AI Superstars. In this article, we are going to take a look at where ...

In a report released today, Michael Wiederhorn from Oppenheimer maintained a Buy rating on HCA Healthcare (HCA – Research Report), with a price ...

Whereas PROS Holdings Inc (NYSE:PRO) was downgraded to "Perform" from "Outperform." Oppenheimer flagged uncertainties around its leadership transition in 2025 and a lack of clarity on achieving a ...

On Thursday, Oppenheimer adjusted its stance on PROS Holdings (NYSE: NYSE:PRO) shares, moving from an Outperform rating to Perform. The change comes as the firm eliminates its previous $27 price ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...